Search

everythinglearnresearchcommunity

for

Search:↓

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Certain drugs that block specific enzymes can help treat prostate diseases.

JAK inhibitors show promise in treating skin conditions like eczema, hair loss, and vitiligo but need more safety research.

JAK inhibitors show promise for treating hair loss in alopecia areata but need more clinical trials to confirm safety and effectiveness.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Baricitinib shows promise for treating alopecia areata with mild side effects.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Five existing drugs may help fight Swine Acute Diarrhea Syndrome Coronavirus.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Baricitinib is an effective treatment for severe alopecia areata.

Arteannuin might work against cancer and Alzheimer's by targeting neprilysin.

Betulinic acid can help treat hepatitis C by stopping virus replication.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

HDAC inhibitors help brain cells grow and improve brain function.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.